Clinical Trial Update: Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study in female breast cancer patients on aromatase inhibitor or tamoxifen; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Que Oncology | Conditions: Vasomotor Symptoms (VMS) | Phase 1 | Status: COMPLETED | Results posted: 2020-02-28